![Jordi Gilberte](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jordi Gilberte
Oprichter bij
GENINCODE PLC
Vermogen: 180 195 $ op 30-06-2026
Profiel
Mr. Jordi P.
Gilberte is a Chief Operations Officer & Executive Director at GENinCode Plc.
He is on the Board of Directors at GENinCode Plc, GEN inCode U.S., Inc. and GENinCode SLU.
Mr. Gilberte was previously employed as a Chief Executive Officer & Director by Ferrer inCode SL and a Chief Financial Officer & Director by Gendiag Exe SL.
He also served on the board at Gendiag SL.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
GENINCODE PLC 1,94% | 31-12-2024 | 14.602.500 ( 1,94% ) | 180 195 $ | 30-06-2026 |
Actieve functies van Jordi Gilberte
| Bedrijven | Functie | Begin |
|---|---|---|
| GENINCODE PLC | Oprichter | 06-09-2018 |
GENinCode SLU | Directeur/Bestuurslid | - |
GEN inCode U.S., Inc. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Jordi Gilberte
| Bedrijven | Functie | Einde |
|---|---|---|
Ferrer inCode SL | Algemeen Directeur | 01-09-2018 |
Gendiag Exe SL
 Gendiag Exe SL BiotechnologyHealth Technology Engages in research and development in biotechnology | Financieel Directeur/CFO | 01-09-2018 |
Gendiag SL
 Gendiag SL BiotechnologyHealth Technology Researches and develops bio technology products | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
7
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Gendiag SL
Gendiag SL BiotechnologyHealth Technology Researches and develops bio technology products | Health Technology |
GENinCode Plc
 GENinCode Plc Packaged SoftwareTechnology Services Develops risk assessment and prediction solutions for cardiovascular disease, thrombosis and familial hypercholesterolemia | Technology Services |
Ferrer inCode SL | |
Gendiag Exe SL
Gendiag Exe SL BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
GENinCode SLU | |
GEN inCode U.S., Inc. |
